MOTS-c (10mg)
MOTS-c (10mg) — Clinical Overview, Mechanism of Action & Provider Dosing Guide
Overview: What Is MOTS-c (10mg)?
MOTS-c (10mg) is a mitochondria-derived peptide (MDP) that plays a key role in cellular energy production and metabolic regulation. It is clinically utilized to enhance mitochondrial performance, support glucose utilization, improve exercise capacity, and assist patients experiencing metabolic resistance or fatigue.
Key Benefits of MOTS-c (10mg)
- Improves Metabolic Flexibility – supports healthier glucose handling and fat utilization
- Increases Energy Production – boosts mitochondrial efficiency and ATP output
- Enhances Physical Performance – often improves endurance and workout response
- Supports Weight-Management Plans – assists those with metabolic slow-downs
- Anti-Inflammatory & Anti-Aging Support – cellular protection properties
- May Improve Insulin Sensitivity – beneficial for high-risk metabolic patients
- Strong Safety Profile – non-hormonal and well tolerated
Mechanism of Action: How MOTS-c (10mg) Works
MOTS-c regulates metabolism at the mitochondrial and genetic level:
- AMPK Activation: Improves sugar uptake and energy conversion
- Mitochondrial Biogenesis Support: Promotes healthier and more efficient mitochondria
- Fat Oxidation Enhancement: Supports metabolic shift toward stored-fat utilization
- Anti-Inflammatory Influence: Reduces oxidative stress and metabolic disruption
- Exercise-Response Upregulation: Enhances endurance and muscle energy output
This creates a high-efficiency metabolic environment, helping patients break through stubborn energy and weight plateaus.
Clinical Dosing Guide for Providers
For licensed medical professionals only.
Suggested Dosage
- Standard Range: 5–10mg weekly
- Dosing Strategy: Single weekly dose or 2–3 smaller doses per week
- Duration: 4–12+ weeks depending on response
Administration Notes
- Route: Subcutaneous injection
- Common Clinical Stacks:
- AOD-9604 — enhanced fat-loss synergy
- GLP-1 analogs — supports appetite + metabolic pathways together
- CJC-1295 / Ipamorelin — hormonal support for muscle preservation
Reconstitution & Storage
- Reconstitute with bacteriostatic water
- Refrigerate immediately after mixing
- ~30-day post-reconstitution stability
Ideal Candidate Profile
Potentially Good Candidates
- Individuals with metabolic slowdown or weight-loss resistance
- Patients with low energy, fatigue, or decreased exercise response
- Those needing improved glucose utilization or insulin sensitivity
- Longevity-focused patients seeking cellular optimization
Use With Caution
- Uncontrolled diabetics — blood glucose must be monitored
- Patients with severe mitochondrial disorders may require specialist oversight
Potential Side Effects
Generally mild and temporary:
- Slight fatigue or headache early in therapy
- Mild injection-site irritation
- Rare GI sensitivity
MOTS-c is non-stimulatory and does not typically affect cardiovascular response.
Frequently Asked Questions
1. What does MOTS-c (10mg) help with?
Metabolic function, cellular energy, and exercise performance.
2. How soon do patients feel a difference?
Often within the first 1–3 weeks — especially during physical activity.
3. Does it work for weight loss?
It supports fat utilization and metabolic efficiency but is not an appetite suppressant.
4. Can MOTS-c help with pre-diabetic markers?
It may improve insulin sensitivity under clinical supervision.
5. Is it taken weekly?
Yes — once weekly or split into multiple doses weekly.
6. Does it increase stamina?
Commonly reported due to improved mitochondrial output.
7. Can it be combined with GLP-1 therapy?
Yes — often used to preserve energy during calorie restriction.
8. Are results permanent?
Ongoing benefits typically require continued lifestyle support.
9. Who should avoid MOTS-c?
Patients with severe uncontrolled metabolic disease until stabilized.
10. How is it stored?
Refrigerated after reconstitution under sterile handling.
MOTS-c (10mg) vs Similar Peptides
- MOTS-c vs AOD-9604:
MOTS-c improves energy metabolism; AOD focuses on fat-breakdown signaling. - MOTS-c vs GLP-1 analogs:
MOTS-c supports energy output; GLP-1 controls appetite + glucose spikes. - MOTS-c vs NAD+ therapies:
Both target cellular health but via different biochemical pathways.
Research & Evidence Overview
Supported by preclinical and emerging human research indicating:
- Improved mitochondrial performance
- Enhanced exercise tolerance
- Better glucose regulation
- Reduced metabolic inflammation
- Anti-aging cellular effects
Clinical use is expanding rapidly in metabolic and longevity programs.
Product & Purity Assurance
99% purity
- COA + endotoxin tested
- cGMP manufacturing compliance
- Provider-only access
Legal & Medical Disclaimer
This information is intended only for licensed medical professionals. This peptide is not intended to diagnose, treat, or cure any condition.

Made in the USA

Third-Party Tested

